AHA GUIDELINES Bundle (free trial)

Dyslipidemia 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1543908

Contents of this Issue

Navigation

Page 8 of 105

9 LDL-C <70 mg/dL (1.8 mmol/L) Non–HDL-C <100 mg/dL (2.6 mmol/L) LDL-C <55 mg/dL (1.4 mmol/L) Non–HDL-C <85 mg/dL (2.2 mmol/L) PREVENT-ASCVD ≥10% • If TG ≥150 mg/dL to 499 mg/dL, apoB goal: <70 mg/dL N/A With FH, ASCVD risk factors, or subclinical atherosclerosis Severe hypercholesterolemia or HeFH with clinical ASCVD With ASCVD risk factors or diabetes-specific risk factors • apoB goal: <70 mg/dL N/A • CAC ≥100 to 299 AU or ≥75th percentile for age, sex, race • CAC ≥300 to 999 AU ° Optional goal: LDL-C <55 mg/dL, non–HDL-C <85 mg/dL and consider apoB goal <55 mg/dL CAC ≥1000 AU • With clinical ASCVD not at very high risk ° apoB goal: <70 mg/dL • Age 40–75 y with ≥1 ASCVD risk factor ° apoB goal: <70 mg/dL With clinical ASCVD at very high risk • apoB goal: <55 mg/dL Not at very high risk • Optional goal: LDL-C <55 mg/dL, non–HDL-C <85 mg/dL and consider apoB goal <55 mg/dL • At very high risk ° apoB goal: <55 mg/dL • With CKD

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Dyslipidemia 2026